BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

In November 2025, the U.S. Food and Drug Administration (FDA) issued several approvals across oncology and supportive care.

AbbVie ABBV has been significantly expanding its presence in the oncology space. What started initially as a two-drug ...

“LYMPHIR is an important new treatment option for the CTCL community, and its launch marks the beginning of a new chapter for Citius Oncology,” Leonard Mazur, chairman and CEO of Citius Oncology and ...

Kura Oncology remains a Strong Buy, driven by Ziftomenib's differentiated safety profile and significant AML market potential ...

Power partnership oncology at MD Anderson expands access to expert cancer care, research, and clinical trials across seven U.S. health systems.

CG Oncology Inc. (NASDAQ:CGON) is one of the best 52-week high stocks to buy right now. On November 24, analysts at Truist ...

Community oncology is crucial for sustainable cancer care, with opportunities in novel therapies, clinical trials, and ...

New grading scales for ocular adverse events in oncology improve clarity and provide drug-dose-modification recommendations, ...

A scoping review identified key factors that ensure an optimal nursing work environment that supports nurses and quality patient care.

Fintel reports that on December 11, 2025, Wedbush initiated coverage of CG Oncology (NasdaqGS:CGON) with a Outperform ...

The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...